at Nasdaq.com (Fri, 12:08PM)
Acorda Therapeutics (ACOR): Q4 EPS of $0.40 may not be comparable to consensus of $0.24. Revenue of $72.6M (+7.2% Y/Y) beats by $3.5M. (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs